BETHLEHEM, Pa., June 2
/PRNewswire/ -- Particle Sciences has expanded its Bioanalytic Service's offerings to include Dried Blood Spot LC/MS/MS analysis (DBS). DBS is a growing area of interest because of its advantages in sample collection, stability, and simplified storage requirements. By using DBS, sample collection and processing is greatly simplified resulting in decreased costs, increased safety and greater comfort for test subjects. According to Laurie Goldman
, Director of Analytic Services at Particle Sciences, "Adding DBS capability is in keeping with Particle Sciences' mandate to be a leader in Analytic Services. While the market is not currently large, this technology is proven and we believe our clients will be increasingly adopting it. To prepare for this, we have been working to bring it in house for the last six months." Robert Lee, Particle Sciences' VP Pharmaceutical Development, adds, "This is a nice addition to our already extensive array of analytic services. Our goal is to provide our clients with start-to-finish services, including early method development, GLP and GMP analytic and bioanalytic services."
About Particle Sciences
Particle Sciences is an integrated provider of drug development services. Particle Sciences focuses on emulsions, gels, particulates and drug/device combination products with additional specialized capabilities in topical and mucosal drug delivery. Through a full range of formulation, analytic, and manufacturing services, Particle Sciences provides pharmaceutical companies with a complete and seamless development solution that minimizes the time and risk between discovery and the clinic. The company was founded in 1991 and is headquartered in Bethlehem, Pennsylvania. Visit www.particlesciences.com, email email@example.com or contact us at (610) 861-4701 for information.
SOURCE Particle Sciences